ST-1891

ST-1891 · Sention Therapeutics, LLC

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ST-1891, covering 2024-08-26 to 2024-08-26. Get the full timeline:

Most recent: Clinical Trial Update: A Study Evaluating the Safety and Efficacy of Hormone Replacement Therapy With ST-1891 Compared to Levothyroxine in Patients With Primary Hypothyroidism [Phase 2]

See pricing